Suchergebnisse - "de Azambuja, E"

PubPharm (12)

1

How we treat patients with metastatic HER2-positive breast cancer

enthalten in: ESMO open | 2022

von Nader-Marta, G. | Martins-Branco, D. | de Azambuja, E.

2

CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer : a systematic review and meta-analysis

enthalten in: ESMO open | 2021

von Agostinetto, E. | Vian, L. | Caparica, R. | +5

3

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Holmes, E. | Bradbury, I. | Williams, L. | +9

CommentIn: Ann Oncol. 2019 Sep 1;30(9):1415-1416. - PMID 31271411

4

ER+/HER2+ breast cancer : are we really de-escalating?

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von de Azambuja, E. | Piccart-Gebhart, M.

CommentOn: Ann Oncol. 2019 Jun 1;30(6):921-926. - PMID 30778520

5

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : Results from Neo-ALTTO

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Di Cosimo, S. | Campbell, C. | Azim, H. | +18

6

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination : A meta-analysis of randomized controlled trials

enthalten in: Cancer treatment reviews | 2017

von Solinas, C. | Ceppi, M. | Lambertini, M. | +9

7

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer : results from the NeoALTTO phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Criscitiello, C. | Azim, H. | de Azambuja, E. | +1

CommentOn: Ann Oncol. 2013 Aug;24(8):1980-5. - PMID 23567146

8

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer : the LAPTEM trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von de Azambuja, E. | Zardavas, D. | Lemort, M. | +13

9

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer : results from the NeoALTTO phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Criscitiello, C. | Azim, H. | Agbor-tarh, D. | +7

CommentIn: Ann Oncol. 2014 Apr;25(4):909-10. - PMID 24608195

10

Genomic grade adds prognostic value in invasive lobular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Metzger-Filho, O. | Michiels, S. | Bertucci, F. | +19